MAOB and ischemic stroke: In summary, our study identified a novel MAO-B inhibitor, ethyl ferulate, which could suppress pro-inflammatory effect in activated microglia and alleviate ischemic brain injury, emerging as a promising candidate for the development of neuroprotectants in the treatment of ischemic stroke.